Faron Pharmaceuticals Finds "Optimal" Patient Group For Traumakine
LONDON (Alliance News) - Faron Pharmaceuticals Ltd shares jumped on Wednesday as the company said it identified an "optimal" subgroup of patients, with a certain genetic mutation, to be Read More